Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > HLVX HilleVax > Detailed Quotes

HLVX HilleVax

Watchlist
12.350
-1.690-12.04%
Trading Session 06/27 10:20 ET
Giving away premium quotes worth 5000 HKD/year to unlock more data
Get NOW
High
14.730
Open
14.730
Turnover
929.26K
Low
12.350
Pre Close
14.040
Volume
67.24K
Market Cap
412.83M
P/E(TTM)
Loss
52wk High
20.950
Shares
33.43M
P/E(Static)
Loss
52wk Low
7.900
Float Cap
167.09M
Bid/Ask %
-33.33%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.80
Historical Low
7.900
Dividend TTM
--
Div Yield TTM
--
P/B
-2.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.50%
Amplitude
16.95%
Avg Price
13.819
Lot Size
1
Float Cap
167.09M
Bid/Ask %
-33.33%
Historical High
20.950
Shs Float
13.53M
Volume Ratio
0.80
Historical Low
7.900
Dividend TTM
--
P/B
-2.45
Dividend LFY
--
Turnover Ratio
0.50%
Amplitude
16.95%
Avg Price
13.819
Lot Size
1
Price Forecast

No Data

News

Comment

Sign in to post a comment

No comment yet

Company Overview More
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
CEO: Hershberg M.D., Ph.D., Robert M.
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top